Correlation Between Edgewise Therapeutics and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Entero Therapeutics,, you can compare the effects of market volatilities on Edgewise Therapeutics and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Entero Therapeutics,.
Diversification Opportunities for Edgewise Therapeutics and Entero Therapeutics,
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Entero is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Entero Therapeutics,
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.56 times more return on investment than Entero Therapeutics,. However, Edgewise Therapeutics is 1.79 times less risky than Entero Therapeutics,. It trades about 0.14 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.04 per unit of risk. If you would invest 608.00 in Edgewise Therapeutics on August 26, 2024 and sell it today you would earn a total of 2,612 from holding Edgewise Therapeutics or generate 429.61% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Entero Therapeutics,
Performance |
| Timeline |
| Edgewise Therapeutics |
| Entero Therapeutics, |
Edgewise Therapeutics and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Entero Therapeutics,
The main advantage of trading using opposite Edgewise Therapeutics and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. HCW Biologics | Edgewise Therapeutics vs. Scpharmaceuticals | Edgewise Therapeutics vs. Milestone Pharmaceuticals |
| Entero Therapeutics, vs. Cardinal Health | Entero Therapeutics, vs. Inflection Point Acquisition | Entero Therapeutics, vs. Aquestive Therapeutics | Entero Therapeutics, vs. Mangazeya Mining |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |